Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT02337634
PHASE2

Milk Thistle in Pathological Gambling

Sponsor: University of Chicago

View on ClinicalTrials.gov

Summary

The goal of the proposed study is to evaluate the efficacy and safety of silymarin in individuals with gambling disorder. The hypothesis to be tested is that silymarin will be more effective and well tolerated in subjects with gambling disorder compared to placebo. The proposed study will provide needed data on the treatment of a disabling disorder that currently lacks a clearly effective treatment.

Official title: Silymarin Treatment of Pathological Gambling: A Double-Blind, Placebo-Controlled Study

Key Details

Gender

All

Age Range

18 Years - 75 Years

Study Type

INTERVENTIONAL

Enrollment

55

Start Date

2015-01

Completion Date

2022-12

Last Updated

2026-07-07

Healthy Volunteers

No

Interventions

DRUG

Placebo

Taken as two 150mg capsules BID for 2 weeks, then 300mg BID for remainder of the study.

DRUG

Milk Thistle

Taken as two 150mg capsules BID for 2 weeks, then 300mg BID for remainder of the study.

Locations (1)

University of Chicago

Chicago, Illinois, United States